Showing results (81-90 of 119) with videos related to
Sort By:
Pageof 12
Biomedical Journal|March 17, 2021
Development of multi-epitope peptide-based vaccines against SARS-CoV-2Hui Xuan Lim, Jianhua Lim, Seyed Davoud Jazayeri, et al.Microbiology (Reading, England)|August 1, 1997
Group II intron from Pseudomonas alcaligenes NCIB 9867 (P25X): entrapment in plasmid RP4 and sequence analysisChew Chieng Yeo, Jill Maelan Tham, Melvyn Wee-Ching Yap, et al.Microbes and Infection|September 25, 2007
Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptideDamian Guang Wei Foo, Sylvie Alonso, Vincent Tak Kwong Chow, et al.Viruses|March 30, 2023
Development of Next Generation Vaccines against SARS-CoV-2 and Variants of ConcernAbdul Aziz Al-Fattah Yahaya, Kanwal Khalid, Hui Xuan Lim, et al.Pharmacological Reports : PR|November 18, 2022
Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient deliveryRaahilah Zahir Essa, Yuan-Seng Wu, Kalaivani Batumalaie, et al.Virus Research|July 27, 2021
Stability and antiviral activity of SP40 peptide in human serumFaisal Zarif, Mohd Ishtiaq Anasir, Jia Xuen Koh, et al.Frontiers in Pharmacology|June 21, 2021
Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious DiseasesSeyed Davoud Jazayeri, Hui Xuan Lim, Kamyar Shameli, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 23, 2007
Inhibition of enterovirus 71 in virus-infected mice by RNA interferenceEng Lee Tan, Theresa May Chin Tan, Vincent Tak Kwong Chow, et al.Antiviral Research|February 24, 2007
Enhanced potency and efficacy of 29-mer shRNAs in inhibition of Enterovirus 71Eng Lee Tan, Theresa May Chin Tan, Vincent Tak Kwong Chow, et al.Vaccines|March 30, 2023
Insights into In Vitro Adaptation of EV71 and Analysis of Reduced Virulence by In Silico PredictionsJia Xuen Koh, Malihe Masomian, Mohd Ishtiaq Anasir, et al.Pageof 12